News › Industry News, News

Syneron Candela Announces FDA Clearance of High Energy UltraShape Power for Fat Destruction

July 22, 2016

WAYLAND, Mass., July 18, 2016 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announces the U.S. Food and Drug Administration (FDA) clearance of its non-invasive fat destruction device, UltraShape Power™. The FDA clearance is for non-invasive reduction of abdominal circumference via fat cell destruction.
UltraShape Power uses focused, pulsed mechanical ultrasound energy to target and destroy fat, offering measurable fat reduction to the abdominal area. UltraShape Power’s advanced USculpt transducer delivers 20% more energy than its predecessor. A recent clinical study with UltraShape Power’s USculpt transducer documents a 32% reduction in subcutaneous fat thickness, positioning UltraShape Power as a powerful solution for non-invasive fat reduction.
 
Continue reading at PR Newswire.
 
 
 
Register Today! A Step-By-Step Guide to Building a Profitable Medical Spa – San Jose, CA: September 19-20, 2016 
A Step-By-Step Guide to Building a Profitable Medical Spa – Dallas, Texas: November 6-7, 2016
Arizona Medical Spa and Medical Aesthetics Regulatory Workshop – Scottsdale, AZ: December 5, 2016

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Hydrafacial Introduces HydraScalp with Keravive
    • CorralData Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Private Equity Bridgepoint Group Acquires Obagi Medical
    • Growth99 Introduces Gia: An AI Front Desk Built to Convert New Patient Inquiries Across Every Channel
    • New Radiesse Research Highlights Deeper Extracellular Matrix Regeneration